PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555734
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555734
Endoscopic Mucosal Resection Market size was valued at USD 1,902.32 Million in 2023, expanding at a CAGR of 7.99% from 2024 to 2032.
Endoscopic Mucosal Resection is a minimally invasive medical procedure used to remove abnormal or precancerous tissue from the lining of the gastrointestinal tract, such as the esophagus, stomach, or colon. By injecting a solution beneath the abnormal tissue to lift it, doctors can safely cut and remove the tissue using an endoscope, a flexible tube with a camera and specialized instruments. EMR is commonly used to treat early-stage cancers or precancerous lesions, allowing for both diagnosis and treatment without the need for open surgery.
Endoscopic Mucosal Resection Market- Market Dynamics
Advancements in Early Diagnosis and Therapeutic Capabilities to Drive Market Growth
Endoscopic Mucosal Resection is highly effective in the early detection and removal of abnormal growths, such as precancerous polyps or early-stage cancers in the gastrointestinal tract. By enabling early diagnosis, EMR significantly increases the likelihood of successful treatment and enhances patient outcomes. Serving both diagnostic and therapeutic roles, EMR allows for precise tissue sampling, aiding in accurate disease diagnosis and staging, while also offering a definitive treatment for small lesions and early-stage cancers. These capabilities are expected to drive the growth of the EMR market, as the demand for minimally invasive procedures with both diagnostic and therapeutic benefits continues to rise
Endoscopic Mucosal Resection Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.99% over the forecast period (2024-2032)
Based on product type segmentation, Lift and Cut technique was predicted to show maximum market share in the year 2023
Based on indication segmentation, Esophageal cancer was the leading type in 2023
On the basis of region, Asia Pacific was the leading revenue generator in 2023
The Global Endoscopic Mucosal Resection Market is segmented on the basis of Product Type, indication, end-user, and Region.
The market is divided into two categories based on product type: Lift and Cut technique is often more prominent due to its precision and effectiveness in safely removing abnormal tissue. This method involves injecting a solution beneath the lesion to lift it from the underlying muscle layer, making it easier to cut and remove with minimal risk of perforation. The Lift and Cut technique is widely favored for its ability to provide clear margins and reduce complications, making it a preferred choice in many clinical settings over the Suck and Cut technique.
The market is divided into four categories based on indication: Esophageal cancer is typically the most dominant segment in the Endoscopic Mucosal Resection (EMR) market due to its high incidence and the critical need for effective treatment strategies. The increasing focus on early detection and the advantages of minimally invasive procedures drive the demand for EMR in this area. As esophageal cancer often presents at advanced stages, early intervention through EMR can significantly improve patient outcomes and survival rates. Additionally, advancements in endoscopic techniques and technology contribute to the growing preference for EMR as a viable treatment option for esophageal cancer.
Endoscopic Mucosal Resection Market- Geographical Insights
The Asia-Pacific landscape of the Endoscopic Mucosal Resection (EMR) market is characterized by rapid growth and increasing adoption due to rising incidences of gastrointestinal cancers and advancements in medical technology. Countries like Japan, China, and India are leading the way, driven by their large patient populations and improving healthcare infrastructure. The region benefits from a growing awareness of early cancer detection and minimally invasive treatment options. Also, local manufacturers and international companies are expanding their presence, contributing to market growth. The emphasis on affordable healthcare solutions and the rising number of specialized medical centers further enhance the market's development in Asia-Pacific.
The competitive landscape of the Endoscopic Mucosal Resection market is shaped by key players like Olympus Corporation and Boston Scientific Corp., who dominate with their advanced endoscopic devices and extensive global reach. Companies such as Cook Medical and CONMED also hold significant market positions, focusing on innovation and expanding their product offerings. Regional players like Micro-Tech (Nanjing) Co. Ltd. and Erbe Elektromedizin GmbH contribute by providing cost-effective solutions and targeting emerging markets. The market is highly competitive, with ongoing investments in research and development, strategic partnerships, and product innovation driving growth and differentiation.
In May 2023, Olympus Europa SE & Co. KG i introduced three Endoclot products in the Europe, Middle East, and Africa (EMEA) region. This launch includes two hemostatic agents and a submucosal injection agent.
In Jan 2023, Agilis Robotics(TM) (Agilis), a leading innovator in flexible robotic instruments for endoscopic surgery, completed the second round of live animal testing with its proprietary robot. This robot is designed to navigate through natural body orifices, such as the gastrointestinal tract and bladder, enhancing minimally invasive surgical procedures.